Summary of treatment recommendations for patients with COVID-19 at Cleveland Clinic
| Mild to moderate illness (no hypoxia, no radiographic pneumonia, oxygen saturation (SpO2) > 94% on room air) Supportive care |
| Severe illness (hypoxia [SpO2 < 94% on room air], radiographic evidence of pneumonia, not critically ill) Supportive care Dexamethasone Remdesivir Infectious disease consult Possibly emerging therapies Possible enrollment in clinical trials |
| Critically ill (mechanically ventilated) Dexamethasone Remdesivir Infectious disease consult Possibly convalescent plasma (in the context of a clinical trial) Possibly emerging therapies Possible enrollment in clinical trials |
| Immunosuppressed patients Consider reduction in immunosuppression in conjunction with rheumatology or oncology consultant Dexamethasone Remdesivir |
| Pregnant patients As above, consider risks and benefits of glucocorticoids and remdesivir |